FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
DOLIPRANE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/28/2026
Trademark type
Word
Nice classes
5
Filing date
06/17/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Opella Healthcare France SAS
Representatives
Jonathan M. Rixen Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and dietary products for medical usepreparations for use in the treatment of pain and fevers
Publications
History of USPTO decisions and trademark events.
26 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/18/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/17/2026
RFNT
REFUSAL PROCESSED BY IB
02/12/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2026
RFRR
REFUSAL PROCESSED BY MPU
01/22/2026
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/19/2025
CNRT
NON-FINAL ACTION WRITTEN
12/18/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
12/18/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/10/2025
CNRT
NON-FINAL ACTION WRITTEN
11/08/2025
DOCK
ASSIGNED TO EXAMINER
11/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/29/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/29/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
08/07/2025
Continuous trademark protection
Get notified about every new filing that threatens DOLIPRANE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.